Target emulation trial of 12,145 Pts (87% female; age 80 yrs), shows that compared to teriparatide, Rx w/ romosozumab was assoc w/ significantly lower risk of osteoarthritis (RR 0.79); especially for knee OA (0.79). https://t.co/nEdENoNae7 https://t.co/JiyRd6ThXu
Links:
Osteoarthritis risk associated with romosozumab compared with teriparatide in i…
https://buff.ly/9wgWjrJ
21-11-2025
